Standardized allergen vaccines in the United States

Allergens and Allergen Immunotherapy, Fourth Edition

Volumn , Issue , 2008, Pages 273-281

  Slater, Jay E ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; VACCINE;

HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; REVIEW; STANDARD; UNITED STATES;

ALLERGENS; HUMANS; HYPERSENSITIVITY; REFERENCE STANDARDS; UNITED STATES; VACCINES;

EID: 58149476671     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (34)

1. Harden VA. A short history of the National Institutes of Health. Available at: http://history.nih.gov/exhibits/history/index.html (Accessed August 2007).
2. Food and Drug Administration. Milestones in U.S. food and drug law history. Available at: http://www.fda.gov/opacom/backgrounders/miles.html (Accessed August 2007).
3. Yunginger JW. Allergenic extracts: characterization, standardization and prospects for the future. Pediatr Clin North Am 1983; 30: 795-805.
4. Baer H, Maloney CJ, Norman PS, et al. The potency and Group I antigen content of six commercially prepared grass pollen extracts. J Allergy Clin Immunol 1974; 54(3): 157-164.
5. Baer H, Godfrey H, Maloney CJ, et al. The potency and antigen E content of commercially prepared ragweed extracts. J Allergy 1970; 45(6): 347-354.
6. Slater JE, Pastor RW. The determination of equivalent doses of standardized allergen vaccines. J Allergy Clin Immunol 2000; 105(3): 468-474.
7. Patterson ML, Slater JE. Characterization and comparison of commercially available German and American cockroach allergen extracts. Clin Exp Allergy 2002; 32: 721-727.
8. Yunginger JW. Allergens: recent advances. Pediatr Clin North Am 1998; 35: 981-993.
9. Food and Drug Administration.Methods of the allergenic products testing laboratory (Docket 94N-0012). Federal Register 1994; 59: 60362-60363.
10. Turkeltaub PC. In-vivo Standardization. In: Middleton EJ, Reed CE, Ellis EF, eds. Allergy, Principles and Practice. St. Louis: C.V. Mosby Co., 1988: 388-401.
11. Turkeltaub PC. Biological standardization of allergenic extracts. Allergol Immunopathol (Madr) 1989; 17(2): 53-65.
12. Turkeltaub PC. Biological standardization. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1997; 91: 145-156.
13. Turkeltaub PC. Allergen Vaccine Unitage Based on Biological Standardization: Clinical Significance. In: Lockey R, Bukantz SC, eds. Allergens and Allergen Immunotherapy. New York: Marcel Dekker, Inc., 1999: 321-340.
14. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen-specific immunotherapy. Allergy 2006; 61(suppl 82): 1-20.
15. van Ree R. The CREATE project: an introduction. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2006;(95): 71-74.
16. Turkeltaub PC, Rastogi SC, Baer H, et al. A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol 1982; 70(5): 343-352.
17. James R, Mitchell H, Gergen PJ, et al. Statistical analysis of ID50EAL data. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2006; 95: 117-127.
18. Slater JE, James R, Pongracic JA, et al. Biological potency of German cockroach allergen extracts determined in an inner city population. Clin Exp Allergy 2007; 37(7): 1033-1039.
19. Turkeltaub PC. In Vivo methods of standardization. Clin Rev Allergy 1986; 4: 371-387.
20. Rabin RL, Slater JE, Lachenbruch P, et al. Sample size considerations for establishing clinical bioequivalence of allergen formulations. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003;(94): 24-33.
21. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15(6): 657-680.
22. Platts-Mills TAE, Rawle F, Chapman MD. Problems in allergen standardization. Clin Rev Allergy 1985; 3: 271-290.
23. Matthews J, Turkeltaub PC. The assignment of biological allergy units (AU) to standardized cat extracts. J Allergy Clin Immunol 1992; 89: 151.
24. Turkeltaub PC, Matthews J. Determination of compositional differences (CD) among standardized cat extracts by in vivo methods. J Allergy Clin Immunol 1992; 89: 151.
25. Turkeltaub PC, Anderson MC, Baer H. Relative Potency (RP), compositional differences (CD), and assignment of allergy units (AU) to mite extracts (Dp and Df) assayed by parallel line skin test (PLST). J Allergy Clin Immunol 1987; 79: 235.
26. Turkeltaub PC. Use of skin testing for evaluation of potency, composition, and stability of allergenic products. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A MInstitut 1994; 87: 79-87.
27. Yunginger JW, Adolphson CR. Standardization of allergens. In: Rose NR, de Macario EC, Fahey JL, et al. eds. Manual of clinical laboratory immunology. Washington, DC: American Society for Microbiology, 1992: 678-684.
28. Lin Y, Miller CA. Standardization of allergenic extracts: an update on CBER’s standardization program. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1997; 91: 127-130.
29. Richman PG, Cissel DS. A procedure for total protein determination with special application to allergenic extract standardization. J Biol Stand 1988; 16(4): 225-238.
30. Slater JE, Gam AA, Solanki MD, et al. Statistical considerations in the establishment of release criteria for allergen vaccines. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2000; 93: 47-56.
31. Food and Drug Administration. Guidance for Reviewers: Potency Limits for Standardized Dust Mite and Grass Allergen Vaccines: A Revised Protocol. Available at: http://www.fda.gov/cber/gdlns/mitegrasvac.pdf (Accessed August 2007).
32. Soldatova LN, Paupore EJ, Burk SH, et al. The stability of house dust mite allergens in glycerinated extracts. J Allergy Clin Immunol 2000; 105(3): 482-488.
33. Finlay WJ, deVore NC, Dobrovolskaia EN, et al. Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins. Clin Exp Allergy 2005; 35(8): 1040-1048.
34. deVore NC, Slater JE. An antibody-based multiplex bead assay to determine the potency and composition of allergen extracts. J Allergy Clin Immunol 2008; 121(2): 557.